These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 35777222)

  • 1. A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.
    Ahmed F; Soomro AM; Chethikkattuveli Salih AR; Samantasinghar A; Asif A; Kang IS; Choi KH
    Biomed Pharmacother; 2022 Sep; 153():113350. PubMed ID: 35777222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence in COVID-19 drug repurposing.
    Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
    Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 5. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Artificial Intelligence in COVID-19 drug repurposing.
    Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening-based approaches.
    Ahmed F; Kang IS; Kim KH; Asif A; Rahim CSA; Samantasinghar A; Memon FH; Choi KH
    J Med Virol; 2023 Apr; 95(4):e28693. PubMed ID: 36946499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods.
    Choudhury C; Arul Murugan N; Priyakumar UD
    Drug Discov Today; 2022 Jul; 27(7):1847-1861. PubMed ID: 35301148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing in silico screening platforms.
    Mullins JGL
    Biochem Soc Trans; 2022 Apr; 50(2):747-758. PubMed ID: 35285479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on drug repurposing applicable to COVID-19.
    Dotolo S; Marabotti A; Facchiano A; Tagliaferri R
    Brief Bioinform; 2021 Mar; 22(2):726-741. PubMed ID: 33147623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Artificial Intelligence for Synergies in Drug Discovery: From Computers to Clinics.
    Arora P; Behera M; Saraf SA; Shukla R
    Curr Pharm Des; 2024; 30(28):2187-2205. PubMed ID: 38874046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
    Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
    Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition.
    Bharadwaj S; Deepika K; Kumar A; Jaiswal S; Miglani S; Singh D; Fartyal P; Kumar R; Singh S; Singh MP; Gaidhane AM; Kumar B; Jha V
    Chem Biol Drug Des; 2024 Oct; 104(4):e14639. PubMed ID: 39396920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.